| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental guanethidine poisoning |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Intentional guanethidine poisoning |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| intoxication par la guanéthidine d'intention indéterminée |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine adverse reaction |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to guanethidine (finding) |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine overdose |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Accidental guanethidine overdose |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Intentional guanethidine overdose |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| surdose de guanéthidine d'intention indéterminée |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine monosulfate [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| monosulfate de guanéthidine 10 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 3% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 0.5%/0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Product containing guanethidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Product containing guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by guanethidine |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine monosulfate |
Is a |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Accidental guanethidine poisoning |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Intentional guanethidine poisoning |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine block |
Direct substance |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing epinephrine and guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Product containing guanethidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Guanethidine block |
Direct substance |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to guanethidine (finding) |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine monosulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
|
| Product containing guanethidine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing guanethidine and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing guanethidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline- and guanethidine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline and guanethidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Guanethidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only guanethidine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only guanethidine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only guanethidine and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only guanethidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Guanethidine 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guanethidine (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]